Catherine A. Shu, MD Profile
Catherine A. Shu, MD

@CatherineShuMD

Followers
357
Following
217
Media
7
Statuses
89

Thoracic medical oncologist @ColumbiaMed. Lucky mother of two lovely children. Board game, food, and grammar enthusiast. Views my own.

Joined May 2022
Don't wanna be here? Send us removal request.
@CatherineShuMD
Catherine A. Shu, MD
9 months
RT @BalazsHalmosMD: CNN breaking news!. You guys might not believe it but early votes are IN!. With 350+ early votes/registrants for the Kr….
0
5
0
@CatherineShuMD
Catherine A. Shu, MD
10 months
Proud to work at @columbiacancer and @nyphospital treating patients with cancer and researching new clinical trial options. NewYork-Presbyterian takes on cancer from every angle via @YouTube.
0
0
3
@CatherineShuMD
Catherine A. Shu, MD
10 months
RT @columbiacancer: We are thrilled to welcome Michel Sadelain, MD, PhD, a global pioneer in CAR-T therapies, to Columbia and the HICCC.
0
7
0
@CatherineShuMD
Catherine A. Shu, MD
11 months
For the class of 2028, being a doctor is indeed a privilege. You get to share a bond with patients at their most vulnerable time. You meet them as a person, not as a CEO or as a movie star. I love my job. Best wishes to you all as you embark on this journey! #columbiavps2028.
0
0
2
@CatherineShuMD
Catherine A. Shu, MD
11 months
Thank you to Dr Jim O’Connell of @BHCHP who gave an incredibly inspirational speech, reminding new medical students that they don’t need to have everything figured out yet! But always to hold onto the basic tenets which brings them here.
0
0
0
@CatherineShuMD
Catherine A. Shu, MD
11 months
On Friday I had the privilege to be a cloaker at the @ColumbiaPS White Coat Ceremony for the Class of 2028. Every physician should attend a White Coat Ceremony once in a while - I’m reminded again of why I became a doctor. #whitecoatceremony #columbiamed
Tweet media one
2
0
6
@CatherineShuMD
Catherine A. Shu, MD
1 year
Thanks @GreatDebatesCME for having me! Turns out there were a lot of secret Swifties in the audience!.
@BalazsHalmosMD
Balazs Halmos
1 year
Dr @CatherineShuMD @GreatDebatesCME is a shoe-in for best Swiftie analogies in a lung cancer talk- including introducing us to the Taylor Swift of thoracic oncology!.Guess whom- Gosh - it is…!.@JSabari
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
1
11
@CatherineShuMD
Catherine A. Shu, MD
2 years
I am thankful for patients like Oswald who make our job so gratifying! Who knew all those years ago we’d be on this path today.
@columbiacancer
Herbert Irving Comprehensive Cancer Center
2 years
In a letter to his oncologist, Dr. Cathy Shu, Oswald Peterson shares how the bond patients form with their doctors can be just as powerful as the treatment they receive. #LungCancerAwarenessMonth @ColumbiaMed @CatherineShuMD.
0
0
3
@CatherineShuMD
Catherine A. Shu, MD
2 years
RT @Exon20Group: PAPILLON triplet = new 1L standard of care (NEJM!) Dr Girard read-out rocks Exon 20 Group! We saw the great outcomes in th….
0
5
0
@CatherineShuMD
Catherine A. Shu, MD
2 years
RT @LeXiuning: I am looking forward to presenting RAMOSE trial in EGFR mut lung cancer pts at #ESMO23 LBA71 @MDAndersonNews @EGFRResisters….
0
8
0
@CatherineShuMD
Catherine A. Shu, MD
2 years
RT @HHorinouchi: PL03.10 MARS 2: A Multicentre Randomised Trial Comparing (Extended) Pleurectomy Decortication versus No Radical Surgery fo….
0
14
0
@CatherineShuMD
Catherine A. Shu, MD
2 years
What an honor to play even a small part of this - thank you to all involved! It was fun hanging out with surgeons, digesting all the new information in this space.
@BrendonStilesMD
Brendon Stiles
2 years
Pleased to share full text link to AATS 2023 Expert Consensus Document: Staging & multidisciplinary management of patients w/ early-stage non-small cell lung cancer. Incredible team effort led by @biniamkidaneMD @DoctorJSpicer & Matt Bott. @AATSHQ #lcsm.
0
0
6
@CatherineShuMD
Catherine A. Shu, MD
2 years
Can’t believe the air quality today. And then of course I can’t stop thinking about Charles Swanton’s paper on lung adenocarcinoma promotion by air pollution…
Tweet media one
0
2
24
@CatherineShuMD
Catherine A. Shu, MD
2 years
RT @Exon20Group: Yes!! Superb @riess_md analysis of Keynote-789, zorifertinib, and sunvozertinib. Promising ORR and CNS activity for #sunv….
0
1
0
@CatherineShuMD
Catherine A. Shu, MD
2 years
Very excited about this one!.
@JackWestMD
H. Jack West, MD, FASCO
2 years
#ASCO23 A9002 (Wang): EGFR exon 20 TKI sunvozertinib appears to be quantum leap over current options for this target, w/ORR 60.8%, active vs. broad range of ex 20 mut'ns, good activity in brain (icRR 48.5%); tox notable for diarrhea & rash, mostly gr 1-2. Real step forward. #LCSM
Tweet media one
Tweet media two
Tweet media three
0
0
2
@CatherineShuMD
Catherine A. Shu, MD
2 years
Yes!!! I see all this all the time in my practice. That being said, it was chilling to see the results of #ADAURA being presented by Roy Herbst!.
@jillfeldman4
Jill Feldman
2 years
Thank you @bensolomon1 for recognizing that while it’s important to celebrate the wins, it’s critical to remember that tolerable is relative and can change over time for those on chronic treatment. #LCSM #ASCO23 @EGFRResisters
Tweet media one
0
0
2
@CatherineShuMD
Catherine A. Shu, MD
2 years
RT @StephenVLiu: When discussing adjuvant osimertinib- can’t downplay chronic toxicity of long term targeted therapy. Dr. @bensolomon1 cred….
0
27
0
@CatherineShuMD
Catherine A. Shu, MD
2 years
RT @CharuAggarwalMD: #ASCO23 @ASCO.KN671 - 1st IA: Periop ChemoIO + Adj IO. Dual endpts EFS/OS.N=797–>397 in P. ✨~40% completed adj tx .✨1/….
0
33
0